ExodusPoint Capital Management’s Surmodics SRDX Stock Holding History

ExodusPoint Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,379	Closed	-$308K	–	1991
2025 Q2	$308K	Sell	10,379 -10,064	-49%	-$290K	﹤0.01%	1241
2025 Q1	$624K	Sell	20,443 -30,962	-60%	-$1.04M	0.01%	1060
2024 Q4	$2.04M	Sell	51,405 -13,529	-21%	-$526K	0.01%	697
2024 Q3	$2.52M	Buy	+64,934	New	+$2.63M	0.02%	642
2024 Q1	–	Sell	-10,410	Closed	-$378K	–	1940
2023 Q4	$378K	Buy	10,410 +575	+6%	+$18.8K	﹤0.01%	1111
2023 Q3	$316K	Buy	+9,835	New	+$334K	﹤0.01%	1404
2020 Q3	–	Sell	-5,375	Closed	-$232K	–	2203
2020 Q2	$232K	Buy	+5,375	New	+$203K	0.01%	1442

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ExodusPoint Capital Management's SRDX Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Surmodics (SRDX) in Q3 2025, closing a stake of 10,379 shares — an estimated $308K sold.

ExodusPoint Capital Management first reported a position in SRDX in Q2 2020 and held it in 7 quarters. The position peaked at $2.52M in Q3 2024. 146 funds tracked by Wall St. Rank hold SRDX as of Q3 2025.

ExodusPoint Capital Management reported no remaining Surmodics position as of Q3 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 10,379 Surmodics shares in Q3 2025, an estimated $308K.
ExodusPoint Capital Management first reported a position in Surmodics in Q2 2020 and held it in 7 quarters.
ExodusPoint Capital Management's Surmodics position peaked at $2.52M in Q3 2024.
146 funds tracked by Wall St. Rank held Surmodics as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.